
Study shows why a common form of immunotherapy fails, and suggests solution
New research has uncovered a mechanism thought to explain why some cancers don't respond to a widely used form of immunotherapy called "checkpoint inhibitors" or anti-PD-1. In addition, the scientists say they have found ...
Aug 5, 2019
0
368